Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using ...

Gain insights into the operational challenges facing clinical research sites today, learn what sponsors and CROs can do to ...

DelveInsight’s “Post Traumatic Stress Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an ...

Intensity Therapeutics (INTS) announces it will present two posters at the San Antonio Breast Cancer Symposium, SABCS, in San Antonio, TX being ...

China Medical System Holdings ( ($HK:0867) ) has shared an update. China Medical System Holdings Limited announced that its New Drug Application ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Knee Osteoarthritis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering ...

MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of ...

Livestream to demonstrate how CXAI is rapidly expanding enterprise adoption, scaling high margin recurring revenue, and moving to capture a 180 to 290 billion dollar enterprise AI opportunity PALO ...

Revenue -- $1.9 billion reported for the quarter, compared to prior sales cycles impacted by earlier U.S. COVID-19 vaccine ...

Summary • HCW Biologics Inc. (HCWB) shares surged 22.73% in after-hours trading to $2.43 following a clinical trial update.• ...